18-13　ⓔ文献

  1. Thiele EA, Korf BR: Phakomatoses and allied conditions. Swaiman’s Pediatirc Neurology: Principles and Practice, 4th ed (Swaiman KF, Ashwal S, et al eds), Mosby, 2012; 497–517.

  2. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol, 1988; 45: 575–578.

  3. Gutmann DH, Aylsworth A, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA, 1997; 2: 51–57.

  4. Roach ES, Gomez MR, et al: Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol, 1998; 13: 624–628.

  5. Kwiatkowski DJ, Whittemore VH, et al ed: Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics, Wiley–Blackwell, 2010.

  6. 樋野興夫編：結節性硬化症の診断と治療最前線，診断と治療社，2016．

  7. 執印太郎：フォン・ヒッペル・リンドウ (VHL) 病診療ガイドライン，中外医学社，2011．

  8. Shirley MD, Tang H, et al: Sturge–Weber syndrome and port–wine stains caused by somatic mutation in GNAQ. New Eng J Med, 2013; 368: 1971–1979.